BRIEF published on 02/18/2026 at 18:35, 8 months 9 days ago Hadrien Lanvin nommé Directeur général délégué du Groupe Aton Biotechnologie Nomination Sciences De La Vie Groupe Aton Hadrien Lanvin
BRIEF published on 02/18/2026 at 18:35, 8 months 9 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 8 months 9 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 8 months 9 days ago Hadrien Lanvin nommé directeur général adjoint du groupe Aton Biotechnologie Croissance Stratégique Directeur Général Adjoint Groupe Aton Hadrien Lanvin
PRESS RELEASE published on 02/18/2026 at 18:30, 8 months 9 days ago ATON ANNONCE LA NOMINATION DE HADRIEN LANVIN AU POSTE DE DIRECTEUR GÉNÉRAL DÉLÉGUÉ Le Groupe Aton nomme Hadrien Lanvin au poste de Directeur général délégué, renforçant ainsi son équipe de direction. Prochaine publication sur Inoviem Scientific et la recherche préclinique Aton Biotechnologies Sciences Médicales Inoviem Scientific Hadrien Lanvin
PRESS RELEASE published on 02/18/2026 at 18:30, 8 months 9 days ago ATON APPOINTS HADRIEN LANVIN AS DEPUTY CEO Aton Group appoints Hadrien Lanvin as Deputy CEO to drive value and visibility, strengthening leadership and strategic positioning. Focus on maximizing asset portfolio valuation and accelerating development Valuation Leadership Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 10/31/2025 at 18:05, 11 months 27 days ago 2025 Half-Year Results: Aton Confirms its Recovery Financial Recovery 2025 Results PIMS Technology Inoviem Scientific B Cell Design
BRIEF published on 10/31/2025 at 18:05, 11 months 27 days ago Résultats semestriels 2025 : Aton confirme son redressement Redressement Financier Résultats 2025 PIMS Technology Inoviem Scientific B Cell Design
PRESS RELEASE published on 10/31/2025 at 18:00, 11 months 27 days ago RESULTATS SEMESTRIELS 2025 Le Groupe Aton annonce une structure financière assainie et le développement de ses filiales lors de sa réunion du 31 octobre 2025. Découvrez les résultats semestriels et les perspectives de croissance Résultats Semestriels Perspectives De Croissance Groupe Aton Réunion Développement Filiales
BRIEF published on 10/08/2025 at 18:05, 1 year ago Strategic partnership between Inoviem Scientific and abc biopply in preclinical oncology Strategic Partnership 3D Models Therapeutic Innovation Preclinical Oncology Translational Pharmacology
Published on 10/27/2026 at 23:40, 1 hour 8 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 1 hour 23 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 3 hours 18 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 3 hours 33 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 3 hours 38 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/27/2026 at 22:40, 2 hours 8 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 2 hours 18 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 4 hours 13 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 5 hours 31 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 18:00, 6 hours 48 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 6 hours 48 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
